Navigation Links
Pharmsynthez Reports Full Year 2012 Results in line US GAAP Financial Reporting
Date:7/17/2013

dicines (Neovir, Segidrin, Fenasid and Penkrofton) used in oncology, gynecology, treatment of immunodeficiencies and tuberculosis.

Financial Review

The growth in consolidated revenue from operations in 2012, as noted above, amounted to $1.8 million, up 27% from 2011. Sales by volume in the Russian Federation increased 6%, while in Ukraine they grew 3.2 times and 1.9 times in Estonia. Together with income from fulfilling R&D contracts financed by the Russian Ministry of Industry and Trade, the Company's revenue totaled $12.7 million.

Consolidated gross profit for 2012 amounted to $4.7 million, up 26% or $1 million from 2011. Meanwhile the gross margin remained almost unchanged at 55%.

In total for 2012 the Company posted a total of $88,000 of comprehensive income in total, versus a loss of $1.2million the previous year.

Pharmsynthez's commercial and management expenses grew 21% from the previous year and amounted to $4.8 million mainly due to salary expenses growth. Furthermore, the Company boosted its operational effectiveness by reducing the share of management expenses in revenue from 36% to 34%.

For 2012 the Company posted a $0.4 million loss on EBITDA versus a $0.4 million profit last year. The main reason for the decline in this indicator was reduced Government co-financing on R&D carried out under contracts with Russia's Ministry of Industry and Trade. In 2012 R&D expenditures significantly exceeded the amount of government co-financing as a result of the company's plans for independent development going forward.

The effect of other operating income in 2012 was minimal compared to 2011, when the Company posted $0.9 million in income from the revaluation of a land plot. Meanwhile, other operating expenses significantly increased to $0.9 million, and their main components, according to the rules for
'/>"/>

SOURCE Pharmsynthez
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Eli Lilly and Company (NYSE: LLY ) will ... on Tuesday, June 9, 2015. Jeffrey Simmons , ... participate in a fireside chat at 2:20 p.m., Eastern ... will be available on the "Webcasts & Presentations" section ... replay of the fireside chat will be available for ...
(Date:5/29/2015)... and BOSTON , May 29, ... instrument development, custom automation, and contract manufacturing, and ... Nanopatch™ needle-free drug delivery technology, have been named winners ... the Nanopatch Jet Coating Instrument , an advanced ... and product development.  The award was announced last evening ...
(Date:5/29/2015)... DIEGO , May 29, 2015  Epic ... cell sequencing data, from metastatic castrate resistant prostate ... the American Society for Clinical Oncology. This application ... no cell left behind™ platform to characterize ... revealed that late stage patients have heterogeneous clonal ...
Breaking Medicine Technology:Lilly to Participate in Goldman Sachs Global Healthcare Conference 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3
(Date:5/29/2015)... 2015 “In the current environment ... federal regulations, we provide education that will help ... are suffering from pain, within the boundaries of ... professor of rehabilitation medicine and President/Medical Director of ... Kansas. , A new flight of PAINWeekEnd Regional ...
(Date:5/29/2015)... 29, 2015 Ready to hit the road? ... all drivers to get their vehicles ready. With handicapped vehicles, ... Advanced Driving Systems (ADS) is ready to help drivers get ... for summer road trips. , When planning for the big ... ensure that the trip goes smoothly and they are prepared ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 ... leap forward in Los Angeles thanks to the efforts ... Dr. Mohebi has combined ARTAS hair restoration ... most advanced hair restoration procedures available anywhere. , A ... of directly and individually harvesting hair follicle grafts from ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... 2015 Abington Hospital – Jefferson ... first hospitals in the nation to join the ... practices and work toward achieving the Baby-Friendly USA© ... focusing on maternity care practices leading to Baby-Friendly ... and Prevention, EMPower is aimed at increasing breastfeeding ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2
... HILL, N.C., April 18 Sales force ... The ability of senior,management to effectively disseminate ... selling time is integral to the overall ... study, "U.S. Sales Communications Excellence:,Resources, Structure and ...
... Fla., April 18 Breckenridge Pharmaceutical,Inc. announced today ... granted,final approval for the Company,s Abbreviated New Drug ... Nordisk,s Activella Tablets,(Estradiol/Norethindrone Acetate 1.0mg / 0.5mg) Tablets., ... Activella(R), a,brand product marketed by Novo Nordisk(R), which ...
... receptors could lead to treatments for other addictions as ... Using gene therapy to increase the level of dopamine ... reduced their desire for cocaine by 75 percent, U.S. ... team at the U.S. Department of Energy,s Brookhaven National ...
... disparities were result of age, body composition , , FRIDAY, ... related to younger age or body composition may not ... higher levels of creatinine than white patients, says a ... , Creatinine is a standard indicator of kidney function. ...
... 18 The American,Chemistry Council (ACC) respects the ... safety of Canadians with respect to the use ... from their,government., Consistent with the safety evaluations ... draft assessment released today by,Health Canada confirms that ...
... April 18 Sales leaders and,organizations that ... mastered,the art of motivating their sales representatives. ... sales personnel can use the key findings,discovered ... "Rewarding &,Recognizing Top-Performing Sales People.",( http://www3.best-in-class.com/dr295.htm ), ...
Cached Medicine News:Health News:Complementary Excerpt Available from Best Practices: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications 2Health News:Gene Therapy in Rats Reduces Cocaine Use 2Health News:Muscle Mass May Not Explain High Creatinine in Black Kidney Patients 2Health News:Health Canada Draft Assessment Supports Safety of Bisphenol A 2Health News:Health Canada Draft Assessment Supports Safety of Bisphenol A 3Health News:Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People 2
... available techniques for prenatal diagnosis (CVS and ... use a small but significant chance of ... care offers invasive prenatal baby gender testing ... chromosomal or genetic abnormalities are greater than ...
... pharmDx Kit is a direct fluorescence in ... determine HER2 gene amplification in formalin-fixed, paraffin-embedded ... determined from the ratio between the number ... HER2 gene probe (red signals) and the ...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
Medicine Products: